BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22997315)

  • 1. Cancer. Emerging anatomy of the BAP1 tumor suppressor system.
    White AE; Harper JW
    Science; 2012 Sep; 337(6101):1463-4. PubMed ID: 22997315
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of the tumor suppressor BAP1 causes myeloid transformation.
    Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM
    Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.
    Hurtado AM; Luengo-Gil G; Chen-Liang TH; Amaral F; Batta K; Palomo L; Lumbreras E; Przychodzen B; Caparros E; Amigo ML; Dıez-Campelo M; Zamora L; Salido Fierrez EJ; Maciejewski JP; Ortuño FJ; Vicente V; Del Canizo M; Sole F; Ferrer-Marin F; Wiseman DH; Jerez A
    Br J Haematol; 2018 Aug; 182(3):373-383. PubMed ID: 29797327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia.
    Padron E; Yoder S; Kunigal S; Mesa T; Teer JK; Al Ali N; Sekeres MA; Painter JS; Zhang L; Lancet J; Maciejewski JP; Epling-Burnette PK; Sotomayor E; Komrokji RS; List AF
    Blood; 2014 Jun; 123(23):3675-7. PubMed ID: 24904105
    [No Abstract]   [Full Text] [Related]  

  • 5. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.
    Kadariya Y; Cheung M; Xu J; Pei J; Sementino E; Menges CW; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
    Cancer Res; 2016 May; 76(9):2836-44. PubMed ID: 26896281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting BAP1: a new paradigm for mesothelioma.
    Schunselaar LM; Zwart W; Baas P
    Lung Cancer; 2017 Jul; 109():145-146. PubMed ID: 28342657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.
    Shen C; Wang Y; Wei P; Du X
    BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia.
    Hasegawa D; Manabe A; Kubota T; Kawasaki H; Hirose I; Ohtsuka Y; Tsuruta T; Ebihara Y; Goto Y; Zhao XY; Sakashita K; Koike K; Isomura M; Kojima S; Hoshika A; Tsuji K; Nakahata T
    Br J Haematol; 2005 Mar; 128(6):805-12. PubMed ID: 15755284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
    Wang SS; Gu YF; Wolff N; Stefanius K; Christie A; Dey A; Hammer RE; Xie XJ; Rakheja D; Pedrosa I; Carroll T; McKay RM; Kapur P; Brugarolas J
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16538-43. PubMed ID: 25359211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
    Damm F; Itzykson R; Kosmider O; Droin N; Renneville A; Chesnais V; Gelsi-Boyer V; de Botton S; Vey N; Preudhomme C; Clavert A; Delabesse E; Park S; Birnbaum D; Fontenay M; Bernard OA; Solary E
    Leukemia; 2013 Jun; 27(6):1401-3. PubMed ID: 23443343
    [No Abstract]   [Full Text] [Related]  

  • 11. Different prognostic roles of tumor suppressor gene BAP1 in cancer: A systematic review with meta-analysis.
    Luchini C; Veronese N; Yachida S; Cheng L; Nottegar A; Stubbs B; Solmi M; Capelli P; Pea A; Barbareschi M; Fassan M; Wood LD; Scarpa A
    Genes Chromosomes Cancer; 2016 Oct; 55(10):741-9. PubMed ID: 27223342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TIF1γ: a tumor suppressor gene in chronic myelomonocytic leukemia].
    Aucagne R; Droin N; Solary E; Bastie JN; Delva L
    Med Sci (Paris); 2011; 27(8-9):696-8. PubMed ID: 21880252
    [No Abstract]   [Full Text] [Related]  

  • 13. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
    Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
    Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
    Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
    Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of BAP1 expression is very rare in breast carcinoma.
    Chui J; Singh A; Gill AJ
    Pathology; 2017 Aug; 49(5):557-560. PubMed ID: 28705347
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene of the month: BAP1.
    Wang A; Papneja A; Hyrcza M; Al-Habeeb A; Ghazarian D
    J Clin Pathol; 2016 Sep; 69(9):750-3. PubMed ID: 27235536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unpigmented nodule with loss of BAP1 expression in a medium-sized congenital nevus.
    Rocas D; Castillo C; Lamarca S; Gallateau-Salle F; Paindavoine S; Pissaloux D; De La Fouchardiere A
    Eur J Dermatol; 2015 Apr; 25(2):201-2. PubMed ID: 25652719
    [No Abstract]   [Full Text] [Related]  

  • 20. Germline mutations in BAP1 impair its function in DNA double-strand break repair.
    Ismail IH; Davidson R; Gagné JP; Xu ZZ; Poirier GG; Hendzel MJ
    Cancer Res; 2014 Aug; 74(16):4282-94. PubMed ID: 24894717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.